Search Our Website:
Nov 10 2021
9:30 AM - 10:30 AM

Edward John Allera, shareholder and co-chair of the firm's FDA group and Matthew Fedowitz, shareholder in the firm’s IP section and Life Sciences industry group, are serving as panelists during the Outsourcing in Clinical Trials conference session, “Is Repurposing Off-Patent Drugs a Viable Development Strategy?